Nemaura Medical Inc. (NMRD)
NMRD Stock Price Chart
Explore Nemaura Medical Inc. interactive price chart. Choose custom timeframes to analyze NMRD price movements and trends.
NMRD Company Profile
Discover essential business fundamentals and corporate details for Nemaura Medical Inc. (NMRD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
5 Feb 2018
Employees
36.00
Website
https://nemauramedical.comCEO
Dewan Fazlul Hoque Chowdhury
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
NMRD Financial Timeline
Browse a chronological timeline of Nemaura Medical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Sept 2025
Earnings released on 30 Jun 2025
Earnings released on 30 May 2025
Earnings released on 21 Mar 2025
Earnings released on 30 Dec 2024
Earnings released on 30 Sept 2024
Earnings released on 26 Aug 2024
Earnings released on 12 Feb 2024
EPS came in at -$0.12 matching the estimated -$0.12.
Earnings released on 13 Nov 2023
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%.
Earnings released on 13 Jul 2023
EPS came in at -$0.18 falling short of the estimated -$0.15 by -20.00%.
Earnings released on 29 Jun 2023
EPS came in at -$0.15 surpassing the estimated -$0.16 by +6.25%, while revenue for the quarter reached -$1.55M , missing expectations by -876.72%.
Earnings released on 24 Feb 2023
EPS came in at -$0.07 surpassing the estimated -$0.18 by +61.11%, while revenue for the quarter reached $3.02K , missing expectations by -98.79%.
Earnings released on 15 Nov 2022
EPS came in at -$0.17 matching the estimated -$0.17, while revenue for the quarter reached $74.03K .
Earnings released on 15 Aug 2022
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%.
Earnings released on 30 Jun 2022
EPS came in at -$0.15 matching the estimated -$0.15, while revenue for the quarter reached $320.28K , missing expectations by -28.83%.
Earnings released on 11 Feb 2022
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%, while revenue for the quarter reached $183.63K , beating expectations by +22.42%.
Earnings released on 15 Nov 2021
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%.
Earnings released on 16 Aug 2021
EPS came in at -$0.14 falling short of the estimated -$0.08 by -75.00%.
Earnings released on 29 Jun 2021
EPS came in at -$0.09 .
Earnings released on 16 Feb 2021
EPS came in at -$0.06 .
Earnings released on 16 Nov 2020
EPS came in at -$0.07 .
NMRD Stock Performance
Access detailed NMRD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.